Contraception
Volume 81, Issue 1 , Pages 79-85, January 2010

A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom® formulations in Cameroonian women

  • Francois-Xavier Mbopi-Keou

      Affiliations

    • Laboratoire de Santé Hygiène Mobile, Ministry of Public Health and Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
    • ,
  • Sylvie Trottier

      Affiliations

    • Infectious Diseases Research Centre and Faculty of Medicine, Université Laval, Centre Hospitalier Universitaire de Québec, Centre Hospitalier de l'Université Laval, Québec, Québec, Canada G1V 4G2
    • ,
  • Rabeea F. Omar

      Affiliations

    • Infectious Diseases Research Centre and Faculty of Medicine, Université Laval, Centre Hospitalier Universitaire de Québec, Centre Hospitalier de l'Université Laval, Québec, Québec, Canada G1V 4G2
    • ,
  • Ngoh N. Nkele

      Affiliations

    • Yaounde Gynaecologic-Obstetric and Pediatric Hospital, Yaoundé, Cameroon
    • ,
  • Séraphin Fokoua

      Affiliations

    • Yaounde Gynaecologic-Obstetric and Pediatric Hospital, Yaoundé, Cameroon
    • ,
  • Enow R. Mbu

      Affiliations

    • Gynaecology Department and Faculty of Medicine and Biomedical Sciences, Central Hospital, University of Yaoundé I, Yaoundé, Cameroon
    • ,
  • Marc-Christian Domingo

      Affiliations

    • Infectious Diseases Research Centre and Faculty of Medicine, Université Laval, Centre Hospitalier Universitaire de Québec, Centre Hospitalier de l'Université Laval, Québec, Québec, Canada G1V 4G2
    • ,
  • Jean-Francois Giguère

      Affiliations

    • Infectious Diseases Research Centre and Faculty of Medicine, Université Laval, Centre Hospitalier Universitaire de Québec, Centre Hospitalier de l'Université Laval, Québec, Québec, Canada G1V 4G2
    • ,
  • Jocelyne Piret

      Affiliations

    • Infectious Diseases Research Centre and Faculty of Medicine, Université Laval, Centre Hospitalier Universitaire de Québec, Centre Hospitalier de l'Université Laval, Québec, Québec, Canada G1V 4G2
    • ,
  • Anthony Mwatha

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, WA 98117, USA
    • ,
  • Benoît Mâsse

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, WA 98117, USA
    • ,
  • Michel G. Bergeron

      Affiliations

    • Infectious Diseases Research Centre and Faculty of Medicine, Université Laval, Centre Hospitalier Universitaire de Québec, Centre Hospitalier de l'Université Laval, Québec, Québec, Canada G1V 4G2
    • Corresponding Author InformationCorresponding author. Tel.: +1 418 654 2705; fax: +1 418 654 2715.

Received 20 April 2009; received in revised form 30 June 2009; accepted 7 July 2009. published online 25 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0010-7824(09)00347-3

doi:10.1016/j.contraception.2009.07.002

Contraception
Volume 81, Issue 1 , Pages 79-85, January 2010

Article Tools